2024-04-18, Thu.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Science & Technology


Calyxt Completes Second Year of Field Trials of its High Oleic Soybean Product

Date: 2015-11-02

NEW BRIGHTON, Minn.--()--Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products to benefit both consumers and farmers, today announced that it has completed the second year of multi-location field trials in Minnesota and South Dakota of its high oleic/no trans fat soybean variety.

For many food applications, standard soybean oil is hydrogenated to improve heat stability and shelf life. This process also increases the amount of saturated fatty acids and creates trans-fats, which have been linked to numerous human health issues. Calyxt has created a non-transgenic variety of soybean with elevated levels of monounsaturated (oleic) fatty acids and decreased levels of saturated fatty acids (palmitic and acid) and polyunsaturated fatty acids (linoleic and linolenic). Compared to standard soybean oil, the Calyxt soybean variety generates oil that eliminates the need for hydrogenation.

The oleic acid content (81%) achieved in Calyxt’s high oleic soybean variety is equal to or exceeds the oleic acid level of transgenic, high oleic soybean varieties currently being grown in the U.S. In addition, the yield of the Calyxt variety in these field trials was equivalent to current conventional varieties, putting Calyxt on the road for a commercial launch of its non-transgenic variety in the next couple of years. Counter-season seed production is currently underway to facilitate a commercial launch in the U.S. while additional field trials are conducted over the next few growing seasons.

“With the recent ban (July 2015) of trans fat products by the FDA, high oleic soybean varieties will likely become the next commodity soybean. The very high amount of oleic acid consistently observed in our field trials demonstrates that our high oleic soybean variety would not only be non-transgenic but also best-in-class to other transgenic high oleic varieties, positioning us as a potential leader,” said Dan Voytas, Chief Scientific Officer of Calyxt, Inc.

About Calyxt

Founded in 2010, Calyxt, Inc. (previously Cellectis plant sciences, Inc.) is based in New Brighton, Minnesota (USA). The company aims to create healthier crop products such as low trans fat soybean oil, cold-storable potato, gluten reduced wheat and low saturated fat canola oil for the food and agriculture industries. Calyxt is developing a network of partnerships in order to secure accessibility of its food products to consumers.

For further information please visit our website: www.calyxt.com

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.



 to the Top List of News

Trinseo Introduces Groundbreaking Flame-retardant Plastic Grades Without Using PFAS Additives During Manufacturing Process
Sintavia Announces $25M Expansion in Hollywood, Florida
Quectel Introduces Versatile BG95-S5 NTN Satellite Communication Module
Neuron Launches Network APIs to Enable Application-Driven QoE On Demand for the Maritime Industry
Quectel Broadens RedCap Offering With Commercial Availability of RG255C-GL RedCap 5G Module
Galaxy AI Now Supports More Languages with Latest Update
Wasabi Technologies Introduces Wasabi AiR, Pioneering Intelligent Media Storage for Sports, Media and Entertainment Industries

 

Adani Green Energy Becomes India¡¯s First to Surpass 10,000 MW Renewab...
Phase 3 Comparative Clinical Study of Prolia and Xgeva (denosumab) Bio...
NetApp Wins Google Cloud Technology Partner of the Year Award for Infr...
VeriSilicon Showcased Its Latest Power-Efficient IP Applications at Em...
Echodyne Showcases MESA Radars at Milipol Asia-Pacific TechX Summit 20...
Adding a Human Touch to AI: LG¡¯s Affectionate Intelligence
FluxSwiss and SwissAI Collaborate on AI-enabled System Modelling for t...
Quectel unveils its HCM511S high performance MCU Bluetooth module to p...
Megaport Launches AWS Direct Connect Network Service Offering on AWS M...
AACR 2024: PDC*line Pharma Presents Interim Clinical Results From Last...

 

 

60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

Copyright, NEWSJI NETWORK.